top of page

Latest News

22.10.26

Six months in: an update on the Hypermarker trial

Six months after its start, the Hypermarker trial has two active enrolling sites, enrolled its first patients, and published its study protocol

Read More
Six months in: an update on the Hypermarker trial

12.6.26

Data Grand Round: Machine Learning Driven Identification of Targeted Metabolites in Hypertension

Hypermarker at the HDR UK Midlands Data Grand Round

Read More
Data Grand Round: Machine Learning Driven Identification of Targeted Metabolites in Hypertension

12.3.26

Hypermarker personalised trial gets the green light

Hypermarker aims to personalise hypertension treatment through metabolomics

Read More
Hypermarker personalised trial gets the green light

16.2.26

Fourth Hypermarker annual meeting in Leiden

Hypermarker Annual Meeting Brings Progress and Collaboration

Read More
Fourth Hypermarker annual meeting in Leiden

17.12.25

Introduction to the Hypermarker Randomised Clinical Trial

Hypermarker aims to personalise hypertension treatment through metabolomics

Read More
Introduction to the Hypermarker Randomised Clinical Trial

Contact Information

 

For more details regarding the Hypermarker project, please reach out to Carl Steinbeisser via email or stay updated by following us on our social media platforms.

​

Email: carl [at] collaborate [dot] eu

EN_FundedbytheEU_RGB_POS.png
UKRI Logo

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

​

This work is also supported by the UKRI Horizon Europe Guarantee scheme.

  • LinkedIn
  • Youtube
Terms of use
Privacy

© 2025 by Collaborate Project Management GmbH. 

bottom of page